Reports

To assist health care providers, policy makers, and consumers in making well-informed decisions about the prescribing and use of insulin analogues, our completed research and resulting recommendations will be available in a series of Optimal  Therapy Reports that provide:

• evidence-based clinical statements and cost-effectiveness statements
• a clear picture of current practice in Canada regarding the use of insulin analogues
• an analysis of the quantity of insulin agents prescribed, including market share and cost information
• an outline of gaps between current prescribing and use.
  

Currently available:

• Summary Reports
  • Project in Brief (one page, re: clinical reports)
  • Executive Summary (eight pages, re: clinical reports)

• Final reports
  • Canadian Agency for Drugs and Technologies in Health. Optimal Therapy Recommendations for the Prescribing and Use of Insulin Analogues. Optimal Therapy Reports – COMPUS 2009; 2 (7).
  • Canadian Agency for Drugs and Technologies in Health. Gap Analysis and Key Messages for the Prescribing and Use of Insulin Analogues. Optimal Therapy Reports – COMPUS 2009; 2 (8).
  • Canadian Agency for Drugs and Technologies in Health.
    Long-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes Update of CADTH Technology Report No. 92
  • Summary of Revisions
  • Canadian Agency for Drugs and Technologies in Health. Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes. Update of CADTH Technology Report No. 87. Optimal Therapy Reports – COMPUS 2008;2(2).
  • Canadian Agency for Drugs and Technologies in Health. GRADE Evidence Profiles on Long- and Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus. Optimal Therapy Reports – COMPUS 2008;2(3).
  • The Canadian Agency for Drugs and Technologies in Health. An Economic Evaluation of Insulin Analogues for the Treatment of Patients with Type 1 and Type 2 Diabetes Mellitus in Canada. Optimal Therapy Reports − COMPUS 2008;2(4)
  • The Canadian Agency for Drugs and Technologies in Health. Current Utilization of Insulin Products in Canada. Optimal Therapy Reports − COMPUS 2008;2(5)
  • Canadian Agency for Drugs and Technologies in Health. Current Practice Analysis: Insulin Analogues. A Qualitative Analysis of Canadian Physician Perceptions and Use of Insulin Analogues. Optimal Therapy Reports – COMPUS 2008;2(6).